Bcl-xL则分布于整个陷窝.Bcl-2蛋白的表达在癌组织和癌旁组织都很低,两者之间差异无统计学意义(Z=0.072,P>0.05);Bcl-xL蛋白的表达均较高,且癌组织高于癌旁组织(Z=3.157,P<0.05);Bax蛋白的表达最强,但在癌组织和癌旁组织之间差异无统计学意义(P>0.05);只有Bcl-2蛋白表达与Dukes分期和TNM分期均成负相关(...
目的 分析STAT3,Bcl-xL,Bax和CyclinD1在非小细胞肺癌和肺正常组织中的表达及关系,以进一步探讨他们与非小细胞肺癌发生发展的关系.方法 利用SABC免疫组织化学技术检测84例非小细胞肺癌组织及30例肺正常组织中STAT3,Bcl-xL,Bax和CyclinDl的表达.结果 (1)STAT3,Bcl-xL和CyclinD1在非小细胞肺癌组织中的表达水平明显...
Provided herein is a combination product comprising a Bcl-2 inhibitor (or a Bcl-2/Bcl-xl dual inhibitor) and a BTK inhibitor, the combination product providing a use in the prevention and/or treatment of a disease (e.g., cancer, autoimmune disease and inflammatory disease.)....
synergistic agents for tumor dissolving viruses.A BCL XL inhibitor and a pharmaceutical composition comprising a tumor lysozyme virus, a BCL XL inhibitor and a drug kit containing a tumor lytic virus, and the use of bcl XL inhibitors and tumor dissolving viruses to treat tumors are disclosed ....